Congrats to this year’s Nobel Prize winners in medicine… although, we have to ask: For the US researchers who are honored, isn’t there something crushing about a call in the middle of the night from Sweden, interrupting a dream about... Read more »
Five years ago, the big tech incubator Y Combinator started to welcome life sciences companies into its sizable startup classes, which had previously nurtured entrepreneurs in information technology almost exclusively.
That opening to biotech startups in 2014 was controversial at the... Read more »
[Updated 7:21 p.m. 10/11. See below.] Scientists, no matter how sexy the research they’re conducting, aren’t immune from the administrative minutiae of office life.
Such tasks steal time away from researchers’ main objectives. However, that wasn’t the problem San... Read more »
This summer Nestlé Health Science sold Prometheus Laboratories, a gastrointestinal disease diagnostics unit it had acquired eight years prior, to a low-profile San Diego biotech called Precision IBD.
About a month ago, Precision—a drug and diagnostic developer that’s focused, as... Read more »
[Updated 5:58 p.m. PT. See below.] Organovo, a company developing technology to 3D print human tissue, announced two months ago that its dwindling cash is leading it to explore options that include merging with another firm. The San... Read more »
UPS, the global package delivery giant, took a minority stake this summer in TuSimple, a self-driving trucking company, but didn’t reveal financial details.
Amplyx Pharmaceuticals, which is testing a new type of drug against life-threatening infections acquired by patients with compromised immune systems, has acquired the rights to another drug that could also be of use in treating those with limited ability to fight... Read more »
Former President and CEO, Regulus Therapeutics
Chief of Genetics, UC San Diego School of Medicine
Professor, Laboratory of Genetics, Salk Institute
Dir., Stem Cell & Regeneration Program, Burnham Institute
Director, UCSD Division of the California Institute for Telecommunications and Information Technology
Professor of Chemistry, Scripps Research Institute
Founding Managing Partner, Forward Ventures
Co-Founder and CEO, Arena Pharmaceuticals
President and CEO, RuiYi.
Executive Partner, Sofinnova Ventures